Summary by Moomoo AI
On February 20, 2024, a significant filing was made with the United States Securities and Exchange Commission (SEC) by New Dimensions Trading Ltd. and Jacob Safier regarding their holdings in T2 Biosystems, Inc. The Schedule 13G filing indicates that New Dimensions Trading Ltd., a company organized under the laws of the Cayman Islands, and Jacob Safier, a United States citizen, collectively own 350,000 shares of T2 Biosystems' common stock, which represents 7.1% of the company's class of securities. This level of ownership triggers the requirement for the Schedule 13G filing under SEC rules. The filing asserts that the shares were not acquired for the purpose of changing or influencing the control of T2 Biosystems, nor were they held in connection with any transaction having that purpose or effect. The filing was signed and dated March 11, 2024, by Chana Edelstein, Director of New Dimensions Trading Ltd., and Jacob Safier, confirming the accuracy of the information provided.